SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-051384
Filing Date
2020-11-05
Accepted
2020-11-05 16:35:26
Documents
14
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K myok-8k_20201105.htm   iXBRL 8-K 41357
2 EX-99.1 myok-ex991_7.htm EX-99.1 251063
3 GRAPHIC gdlszudzrqwu000001.jpg GRAPHIC 17233
  Complete submission text file 0001564590-20-051384.txt   456257

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA myok-20201105.xsd EX-101.SCH 5780
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20201105_lab.xml EX-101.LAB 18708
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20201105_pre.xml EX-101.PRE 11176
7 EXTRACTED XBRL INSTANCE DOCUMENT myok-8k_20201105_htm.xml XML 3417
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 201291051
SIC: 2834 Pharmaceutical Preparations